ArticleMikrochimica acta2025
MOF-818 nanozyme-based biosensor for specific point-of-care testing of Bacillus subtilis in complex agricultural soil.
Article in Mikrochimica acta, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Bacillus subtilis (BS) effectively suppresses soilborne pathogens and enhances crop resistance through various mechanisms. However, its efficacy is significantly influenced by effective inter-root colonization rates, among other factors, necessitating precise quantitative monitoring for optimal application. Conventional detection methods are often time-consuming and technically demanding, limiting their application in the field. To address this challenge, we developed a dual-recognition biosensing platform. Specifically, tridentate-functionalized aptamer was utilized for rapid BS enrichment and secondary recognition achieved using fragment crystallizable mannose-binding lectin (FcMBL)-modified nanozyme (MOF-818). The rigid scaffold of MOF-818 ensured superior catechol oxidase activity and environmental stability, facilitating sensitive and robust online quantification of BS in complex soil matrices. The linear detection range of the platform was 10
Indexed as
Identifiers
41175228What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.